Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neha Korde

Showing results (1-10 of 125) with videos related to

Pageof 13
Sort By:
Seminars in Oncology|January 8, 2017
Treatment of high-risk smoldering myelomaNeha Korde
Oncology (Williston Park, N.Y.)|September 6, 2011
Multiple myeloma precursor disease: current clinical and epidemiological insights and future opportunitiesOla Landgren, Neha Korde
Seminars in Oncology|February 9, 2022
Examining health related quality of life outcomes in multiple myeloma: Past and future perspectivesGil Hevroni, Neha Korde
Blood|September 1, 2012
Treating myeloma: the future is already here!Ola Landgren, Neha Korde
Seminars in Hematology|January 15, 2011
Myelomagenesis: capturing early microenvironment changesNeha Korde, Irina Maric
Hematology/Oncology and Stem Cell Therapy|August 3, 2021
Cross Fire: Daratumumab-Based Therapies Are Standard of Care in Newly Diagnosed Multiple MyelomaNeha Korde, Saad Z Usmani
The New England Journal of Medicine|May 11, 2012
Bortezomib to treat the TEMPI syndromeMary Kwok, Neha Korde, Ola Landgren
Clinical Lymphoma, Myeloma & Leukemia|December 10, 2014
The road to treating smoldering multiple myelomaNeha Korde, Sham Mailankody, Ola Landgren
Blood|March 29, 2011
Monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM): novel biological insights and development of early treatment strategiesNeha Korde, Sigurdur Y Kristinsson, Ola Landgren
JCO Oncology Practice|June 17, 2026
Practical Management of Bispecific Antibodies in Multiple MyelomaCarlyn Rose Tan, Neha Korde, Hira Mian
Pageof 13

Showing results (1-10 of 125) with videos related to

Sort By:
Pageof 13
Seminars in Oncology|January 8, 2017
Treatment of high-risk smoldering myelomaNeha Korde
Oncology (Williston Park, N.Y.)|September 6, 2011
Multiple myeloma precursor disease: current clinical and epidemiological insights and future opportunitiesOla Landgren, Neha Korde
Seminars in Oncology|February 9, 2022
Examining health related quality of life outcomes in multiple myeloma: Past and future perspectivesGil Hevroni, Neha Korde
Blood|September 1, 2012
Treating myeloma: the future is already here!Ola Landgren, Neha Korde
Seminars in Hematology|January 15, 2011
Myelomagenesis: capturing early microenvironment changesNeha Korde, Irina Maric
Hematology/Oncology and Stem Cell Therapy|August 3, 2021
Cross Fire: Daratumumab-Based Therapies Are Standard of Care in Newly Diagnosed Multiple MyelomaNeha Korde, Saad Z Usmani
The New England Journal of Medicine|May 11, 2012
Bortezomib to treat the TEMPI syndromeMary Kwok, Neha Korde, Ola Landgren
Clinical Lymphoma, Myeloma & Leukemia|December 10, 2014
The road to treating smoldering multiple myelomaNeha Korde, Sham Mailankody, Ola Landgren
Blood|March 29, 2011
Monoclonal gammopathy of undetermined significance (MGUS) and smoldering multiple myeloma (SMM): novel biological insights and development of early treatment strategiesNeha Korde, Sigurdur Y Kristinsson, Ola Landgren
JCO Oncology Practice|June 17, 2026
Practical Management of Bispecific Antibodies in Multiple MyelomaCarlyn Rose Tan, Neha Korde, Hira Mian
Pageof 13